Stay informed with a short, sharp monthly summary of MLA’s latest research reports.
MLA (and various collaboration partners) invests and generates intellectual property. Where applicable, MLA licences technologies with an emphasis on improving the Australian beef, sheep and goat industries.
MLA's passion to innovate and improve industry, coupled with expertise in IP protection and commercialisation, ensures a high level of commercial IP is licenced. We’re energised by potential solutions, no matter how big or how small. Some of the new commercial technology areas include diagnostics, animal treatments, vaccines, remote assessment, waste removal, new energy, robots and genetic assessment.
Below are technologies seeking commercial partners.
The available technology portfolio is constantly changing and not all technologies are advertised. So please contact us if you are exploring solutions to industry problems.
MLA also have strong networks throughout all sectors of industry and are always looking for new ideas to invest in. Visit the MLA Donor Company for more information.
Contact
Amanda McAlpine - Program Manager - Commercialisation & Intellectual Property
P: +61 (2) 9463 9228 M: +61 406 428 395
MLA, LiveCorp and University of Technology Sydney researchers are seeking interested partners to further develop and commercialise automated livestock counting technology for live export yards and vessels, saleyards and farms.
MLA and Queensland University of Technology are seeking partners to further trial and deliver a cattle dags treatment.
MLA and University of Sydney are seeking partners to further trial and deliver a Johne's vaccine for sheep and cattle.
Charles Sturt University and MLA have identified a potential preventative and treatment for Perennial Ryegrass Toxicity.
The Department of Agriculture and Fisheries and MLA have developed an innovative cattle vaccine platform targeted at reducing the incidence of bovine respiratory disease complex (BRDC).
For more information: Email Amanda McAlpine, Program Manager, Commercialisation and IP, or phone 0404 025 963 or 02 9463 9228.
The Department of Agriculture and Fisheries, University of Queensland and MLA have identified nine novel antigens for use in a vaccine to reduce the incidence of cattle tick.
For more information: Email Amanda McAlpine, Program Manager, Commercialisation and IP, or phone 0404 025 963 or 02 9463 9228.
MLA are seeking interested partners to further develop and commercialise a novel pain relief pour-on treatment for Australian cattle.
James Cook University, CSIRO and MLA are seeking partners to further trial and test this supplement to reduce methane and increase productivity.
For more information: Email Amanda McAlpine, Program Manager, Commercialisation and IP, or phone 0404 025 963 or 02 9463 9228.
Broad spectrum, easily developed, cost effective salmonella vaccine. Just licenced, undergoing vaccine upscaling and registration trialling.
For more information: Email Amanda McAlpine, Program Manager, Commercialisation and IP, or phone 0404 025 963 or 02 9463 9228.
For use in livestock applications including a intraruminal device.
For more information: Email Amanda McAlpine, Program Manager, Commercialisation and IP, or phone 0404 025 963 or 02 9463 9228.
For livestock use: an opportunity is available via MLA.
Use of genomic data and algorithms to accurately identify the breed content of individual animals or groups of animals, or tissue samples (such as meat or wool) derived from individual animals or groups of animals.
For more information: Email Amanda McAlpine, Program Manager, Commercialisation and IP, or phone 0404 025 963 or 02 9463 9228.
For more information: Email Amanda McAlpine, Program Manager, Commercialisation and IP, or phone 0404 025 963 or 02 9463 9228.
